Business Wire

CA-AMBARELLA

21.6.2021 11:02:09 CEST | Business Wire | Press release

Share
Ambarella Expands Security AI Vision SoC Portfolio With Two New Families; Doubles Resolution to 32MP30 for 4K Multi-Imager Cameras With Advanced AI

Ambarella, Inc. (NASDAQ: AMBA), an AI vision silicon company, today announced the expansion of its AI vision SoC portfolio with the new CV5S and CV52S security families. Based on the CVflow® architecture and advanced 5nm process technology, the new SoCs support simultaneous 4K encoding and advanced AI processing in a single low-power design, which provides industry-leading edge AI SoC performance per watt. The CV5S family is ideal for security camera applications that require multiple sensors for 360-degree coverage, over a wide area and with a long range, such as outdoor city environments or large buildings. The CV52S family is designed for single-sensor security cameras with advanced AI performance that need to more clearly identify individuals or objects in a scene, including faces and license plate numbers over long distances, such as ITS traffic cameras.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210621005178/en/

“Security system designers desire higher resolutions, increasing channel counts, and ever faster and more ubiquitous AI capabilities,” explained John Lorenz, senior technology & market analyst, computing at Yole Développement (Yole). “Ambarella’s newest AI vision SoCs for security, the CV5S and CV52S, are competitive solutions for meeting the growing demands of the security IC sector, which we forecast to exceed $4 billion by 2025, with two-thirds of that being chips with AI capabilities.” (1)

The new CV5S SoC family supports multi-imager camera designs and can simultaneously process and encode four imager channels of up to 8MP, or 4K resolution, each at 30 frames per second (fps), while performing advanced AI on each 4K imager. These SoCs double the encoding resolution and memory bandwidth while consuming 30% less power than Ambarella’s prior generation.

The new CV52S SoC family targets single-sensor security cameras and supports 4K resolution at 60fps, while providing 4x the AI computer vision performance, 2x the CPU performance and 50% more memory bandwidth than its predecessors. This increase in neural network (NN) performance enables more AI processing to be performed at the edge, instead of in the cloud.

“The global security industry is rapidly moving to higher 4K resolutions while increasing AI algorithm capabilities, to achieve better recognition of people and objects, along with multiple imagers for a wider field of view and longer range,” said Jerome Gigot, senior director of marketing, Ambarella. “Our new CV5S and CV52S security AI vision SoC families respectively support 4K multi-imager or high-frame-rate 4K single-imager designs with high performance edge AI processing, allowing the development of cameras that do not need to compromise between image resolution and AI processing accuracy.”

In addition to security, there are many other AIoT applications that can take advantage of the high resolution and advanced AI processing provided by these new SoC families. For example, smart cities can leverage high edge AI performance and image resolution for improved traffic management, accident detection and automated speed control, as well as the rapid location of missing and stolen vehicles. Likewise, smart retail operations can use this resolution and advanced AI to better manage product placement, adjust cashier staffing for real-time line management, enhance warehouse product tracking, and provide more actionable intelligence at both the store and corporate levels.

Additional features of the new CV5S and CV52S families include:

  • Robust SDK created specifically for the security camera market
  • CVflow tools that are compatible across all security families
  • Dual Arm® A76 1.6GHz CPUs with 1MB of L3 memory; a 2x performance gain over the prior generation for faster customer applications
  • Enhanced ISP with excellent HDR, ISO low-light, dewarping and rotation performance
  • On-chip privacy masking to block out a portion of the captured scene
  • New PCIe and USB 3.2 interfaces, enabling more complex, multi-chip security system designs than prior generation
  • Strong on-chip cybersecurity hardware to ensure secure IP cameras, including secure boot, OTP and Arm TrustZone technology
  • Multiple video inputs, with support for up to 14 cameras using MIPI virtual channels
  • SLVS-EC interface on the CV5S for reduced system design complexity
  • Support for LPDDR4x, LPDDR5 and LPDDR5x DRAM

Availability

The CV5S and CV52S SoC families are expected to be available for sampling in October. For more information, contact Ambarella: https://www.ambarella.com/contact-us/ .

About Ambarella

Ambarella’s products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving and robotics applications. Ambarella’s low-power systems on chip (SoCs) offer high-resolution video compression, advanced image processing and powerful deep neural network processing to enable intelligent cameras to extract valuable data from high-resolution video streams. For more information, please visit www.ambarella.com

All brand names, product names, or trademarks belong to their respective holders. Ambarella reserves the right to alter product and service offerings, specifications, and pricing at any time without notice. © 2021 Ambarella. All rights reserved.

1. Source: Cameras and computing for surveillance and security report , Yole Développement, 2020

Link:

ClickThru

Social Media:

https://www.facebook.com/ambarellacorp/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye